ARROWHEAD PHARMACEUTICALS INC
For the period ended Sep 30, 2024. Filed Nov 26, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Nov 26, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
ITEM 13. CERTAIN RELATIONSHIPS, ELATED TRANSACTIONS AND DIRECTORS NDEPENDENCE
ITEM 13. CERTAIN RELATIONSHIPS, RELATED TRANSACTIONS AND DIRECTOR INDEPENDENCE
The information called for by this Item will be incorporated by reference from the Definitive Proxy Statement, under the headings Review and Approval of Related-Party Transactions and Certain Relationships and Related Transactions, and Director Independence.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.